Literature DB >> 11445452

Immunity to Bordetella pertussis.

K H Mills1.   

Abstract

Bordetella pertussis exploits extracellular and intracellular niches in the respiratory tract and a variety of immune evasion strategies to prolong its survival in the host. This article reviews evidence of complementary roles for cellular and humoral immunity in protection. It discusses the effector mechanisms of bacterial elimination, the strategies employed by the bacteria to subvert protective immune responses and the immunological basis for systemic and neurological responses to infection and vaccination.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11445452     DOI： 10.1016/s1286-4579(01)01421-6

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  70 in total

1.  Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Charlotte Andreasen; Edward Dudley; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

2.  Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.

Authors:  Pádraig J Ross; Ed C Lavelle; Kingston H G Mills; Aoife P Boyd
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

3.  Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

Authors:  Michael W Henderson; Carol S Inatsuka; Amanda J Sheets; Corinne L Williams; David J Benaron; Gina M Donato; Mary C Gray; Erik L Hewlett; Peggy A Cotter
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

Review 4.  Th17 cytokines and vaccine-induced immunity.

Authors:  Yinyao Lin; Samantha R Slight; Shabaana A Khader
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

5.  Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression.

Authors:  Giorgio Fedele; Paola Stefanelli; Fabiana Spensieri; Cecilia Fazio; Paola Mastrantonio; Clara M Ausiello
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Infection of newborn piglets with Bordetella pertussis: a new model for pertussis.

Authors:  S Elahi; R Brownlie; J Korzeniowski; R Buchanan; B O'Connor; M S Peppler; S A Halperin; S F Lee; L A Babiuk; V Gerdts
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction.

Authors:  Fabiana Spensieri; Giorgio Fedele; Cecilia Fazio; Maria Nasso; Paola Stefanelli; Paola Mastrantonio; Clara Maria Ausiello
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

8.  Improved efficacy of a licensed acellular pertussis vaccine, reformulated in an adjuvant emulsion of liposomes in oil, in a murine model.

Authors:  Marc Mansour; Robert G Brown; Annette Morris; Bruce Smith; Scott A Halperin
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

Review 9.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

10.  Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines.

Authors:  Françoise Vermeulen; Virginie Verscheure; Eliane Damis; Danièle Vermeylen; Gaëlle Leloux; Violette Dirix; Camille Locht; Françoise Mascart
Journal:  Clin Vaccine Immunol       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.